Re: Great Presetation today

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

BearDownAZ

Rank: President [?]

Points: 25003 [?]

Votes: 68 Score: 4.5 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Great Presetation today

posted on Oct 17, 2017 03:14PM

Very encouraging....especially for the enzalutamide/ZEN-3694 combo data shown in slides 17 and 18!

Here's the slide deck

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply